4DMedical posts FY26 revenue growth as commercial deployment ramps up
4DMedical reports 21% FY26 revenue growth as CT:VQ gains commercial adoption, global regulatory approvals and major healthcare partnerships.
Market Cap $64.62M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| M7T | Changes to Company Secretary and Registered Office | 23/04/18 | ||
| M7T | Cleansing Notice | 18/04/18 | ||
| M7T | Appendix 3B | 18/04/18 | ||
| M7T | Mach7 Quarterly Update | PRICE SENSITIVE | 12/04/18 | |
| M7T | Appendix 4C - quarterly | PRICE SENSITIVE | 12/04/18 | |
| M7T | Mach7 Establishes Industry Advisory Board | 21/03/18 | ||
| M7T | Half Year Results Presentation | 07/03/18 | ||
| M7T | Half Yearly Results Announcement | PRICE SENSITIVE | 26/02/18 | |
| M7T | Appendix 4D and Half Yearly Report | PRICE SENSITIVE | 26/02/18 | |
| M7T Changes to Company Secretary and Registered Office | |||
| 23/04/18 | |||
| M7T Cleansing Notice | |||
| 18/04/18 | |||
| M7T Appendix 3B | |||
| 18/04/18 | |||
| M7T Mach7 Quarterly Update | |||
| 12/04/18 | PRICE SENSITIVE | ||
| M7T Appendix 4C - quarterly | |||
| 12/04/18 | PRICE SENSITIVE | ||
| M7T Mach7 Establishes Industry Advisory Board | |||
| 21/03/18 | |||
| M7T Half Year Results Presentation | |||
| 07/03/18 | |||
| M7T Half Yearly Results Announcement | |||
| 26/02/18 | PRICE SENSITIVE | ||
| M7T Appendix 4D and Half Yearly Report | |||
| 26/02/18 | PRICE SENSITIVE | ||